Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Radiotherapy × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 12 Prostatic Neoplasms 10 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Glioma 7 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Oropharyngeal Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Rectal Neoplasms 3 Radiation Injuries 3 Carcinoma 3 Vaginal Neoplasms 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoma, Follicular 2 Liposarcoma 2 Leiomyosarcoma 2

Interventions

Rituximab 11 Cyclophosphamide 7 Lenalidomide 5 zanubrutinib 4 venetoclax 4 Vincristine 4 orelabrutinib 3 fludarabine 3 Prednisone 3 Doxorubicin 3 CT-P10 3 pirtobrutinib 2 obinutuzumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 voruciclib 1 treosulfan 1 tislelizumab 1 prednylidene 1 pembrolizumab 1 ixazomib 1 ibrutinib 1 glofitamab 1 deltacortene 1 cc-486 1 Stem Cell Transplantation 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡